Clinical Trials Browser

Brain Neoplasms

Brain Neoplasms, Neoplasms

Brain Neoplasms

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Brain Neoplasms, Neoplasm Metastasis

Brain Neoplasms, Carcinoma, Renal Cell

Brain Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Brain Neoplasms, Necrosis, Seizures

Margins of Excision, Brain Neoplasms, Fasting

Brain Neoplasms

Brain Neoplasms, Glioblastoma

Brain Neoplasms

Brain Neoplasms

Brain Neoplasms, Cranial Nerve Diseases, Central Nervous System Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Glioblastoma, Neoplasm Metastasis, Meningeal Carcinomatosis

Brain Neoplasms, Triple Negative Breast Neoplasms

Brain Neoplasms, Medulloblastoma

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

Brain Neoplasms, Meningioma

Brain Neoplasms

Brain Neoplasms, Neoplasms

Brain Neoplasms, Melanoma

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Brain Neoplasms, Neoplasm Metastasis

Brain Neoplasms

Brain Neoplasms

Brain Neoplasms

Brain Neoplasms, Glioblastoma

Brain Neoplasms, Breast Neoplasms

Brain Neoplasms

Brain Neoplasms, Breast Neoplasms

Brain Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms, Melanoma

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms, Melanoma

Brain Neoplasms, Melanoma

Brain Neoplasms

Brain Neoplasms

Brain Neoplasms, Glioblastoma

Brain Neoplasms

Brain Neoplasms, Glioma

Brain Neoplasms, Colonic Neoplasms, Glioblastoma, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Brain Neoplasms

Brain Neoplasms

Clinical Trials

NTS-WBRT in Brain Metastases

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Palbociclib and Pembrolizumab In Central Nervous System Metastases

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

Brain Imaging Biomarkers in Patients With Brain Metastasis

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

REPOSE

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

ABC-X

ARISTOCRAT

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

EViDENCE-BM

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

CONCORDANT

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

RAD101

Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis

ENCEFALO

TROPICAL-1

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

SPARTA

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

RAPPLE